PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 11, Issue 9, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-24
DOI
10.1038/s41419-020-02998-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer
- (2020) Zeting Yuan et al. BRITISH JOURNAL OF CANCER
- Mechanisms of Multidrug Resistance in Cancer Chemotherapy
- (2020) Karol Bukowski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The PI3K/AKT Pathway Inhibitor ISC-4 Induces Apoptosis and Inhibits Growth of Leukemia in Preclinical Models of Acute Myeloid Leukemia
- (2020) Charyguly Annageldiyev et al. Frontiers in Oncology
- Y6, an Epigallocatechin Gallate Derivative, Reverses ABCG2-Mediated Mitoxantrone Resistance
- (2019) Rui-Qiang Zhao et al. Frontiers in Pharmacology
- Vielanin P enhances the cytotoxicity of doxorubicin via the inhibition of PI3K/Nrf2-stimulated MRP1 expression in MCF-7 and K562 DOX-resistant cell lines
- (2019) Hong-Liang Gao et al. PHYTOMEDICINE
- Down‐regulated lncRNA SLC25A5‐AS1 facilitates cell growth and inhibits apoptosis via miR‐19a‐3p/PTEN/PI3K/AKT signalling pathway in gastric cancer
- (2019) Xiwen Li et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Guajadial reverses multidrug resistance by inhibiting ABC transporter expression and suppressing the PI3K/Akt pathway in drug-resistant breast cancer cells
- (2019) Yaxun Li et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Establishing Cerebral Organoids as Models of Human-Specific Brain Evolution
- (2019) Alex A. Pollen et al. CELL
- Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells
- (2019) Yongjun Li et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Costunolide enhances sensitivity of K562/ADR chronic myeloid leukemia cells to doxorubicin through PI3K/Akt pathway
- (2019) Hong Cai et al. PHYTOTHERAPY RESEARCH
- Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance
- (2019) Meran Keshawa Ediriweera et al. SEMINARS IN CANCER BIOLOGY
- The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling
- (2019) Dong-ming Wu et al. Cell Death & Disease
- Countering TRAIL Resistance in Melanoma
- (2019) Jürgen Eberle Cancers
- mTOR Signaling Pathway in Cancer Targets Photodynamic Therapy In Vitro
- (2019) Sandra M. Ayuk et al. Cells
- Targeting the phosphoinositide 3-kinase/AKT pathways by small molecules and natural compounds as a therapeutic approach for breast cancer cells
- (2019) Amin Soltani et al. MOLECULAR BIOLOGY REPORTS
- Insights into new mechanisms and models of cancer stem cell multidrug resistance
- (2019) Y. Garcia-Mayea et al. SEMINARS IN CANCER BIOLOGY
- Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications
- (2019) Monica Marzagalli et al. SEMINARS IN CANCER BIOLOGY
- AKT1-targeted proapoptotic activity of compound K in human breast cancer cells
- (2019) Eunju Choi et al. Journal of Ginseng Research
- Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance
- (2019) Monish Ram Makena et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dihydroartemisinin suppresses glycolysis of LNCaP cells by inhibiting PI3K/AKT pathway and downregulating HIF-1α expression
- (2019) Wenhe Zhu et al. LIFE SCIENCES
- Comparison of LC-MS/MS-based targeted proteomics and conventional analytical methods for monitoring breast cancer resistance protein expression
- (2019) Huanhuan Li et al. LIFE SCIENCES
- AKT1 internal tandem duplications and point mutations are the genetic hallmarks of sclerosing pneumocytoma
- (2019) Yi-Chen Yeh et al. MODERN PATHOLOGY
- Transgelin 2 promotes paclitaxel resistance, migration and invasion of breast cancer by directly interacting with PTEN and activating PI3K/Akt/GSK-3β pathway
- (2019) Leichao Liu et al. MOLECULAR CANCER THERAPEUTICS
- Involvement of Mitochondrial Dysfunction, Endoplasmic Reticulum Stress, and the PI3K/AKT/mTOR Pathway in Nobiletin-Induced Apoptosis of Human Bladder Cancer Cells
- (2019) Yih-Gang Goan et al. MOLECULES
- Metabolome Analysis Reveals Dermal Histamine Accumulation in Murine Dermatitis Provoked by Genetic Deletion of P-Glycoprotein and Breast Cancer Resistance Protein
- (2019) Naoto Hashimoto et al. PHARMACEUTICAL RESEARCH
- Wnt-β-catenin signaling pathway, the Achilles' heels of cancer multidrug resistance
- (2019) Morteza Ghandadi et al. CURRENT PHARMACEUTICAL DESIGN
- Targeting AKT for cancer therapy
- (2019) Maryam Shariati et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The Antitumor Effect of Lipophilic Bisphosphonate BPH1222 in Melanoma Models: The Role of the PI3K/Akt Pathway and the Small G Protein Rheb
- (2019) Rittler et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma
- (2019) Farzad Rahmani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Synergistic growth inhibition mediated by dual PI3K/mTOR pathway targeting and genetic or direct pharmacological AKT inhibition in human glioblastoma models
- (2019) Caroline Von Achenbach et al. JOURNAL OF NEUROCHEMISTRY
- ATM Regulated PTEN Degradation Is XIAP E3 Ubiquitin Ligase Mediated in p85α Deficient Cancer Cells and Influence Platinum Sensitivity
- (2019) Reem Ali et al. Cells
- Zhankuic Acids A, B and C from Taiwanofungus camphoratus Act as Cytotoxicity Enhancers by Regulating P-Glycoprotein in Multi-Drug Resistant Cancer Cells
- (2019) Yu-Ning Teng et al. Biomolecules
- Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway
- (2019) Maria M. Rubinstein et al. CANCER
- Reversible inhibition of efflux transporters by hydrogel microdevices
- (2019) Elizabeth S. Levy et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- PI3K Inhibitors in Breast Cancer Therapy
- (2019) Haley Ellis et al. Current Oncology Reports
- miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cells
- (2018) Dan Yue et al. CANCER GENE THERAPY
- The Critical Role of PTEN/PI3K/AKT Signaling Pathway in Shikonin-Induced Apoptosis and Proliferation Inhibition of Chronic Myeloid Leukemia
- (2018) Yu Chen et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- SHBG expression is correlated with PI3K/AKT pathway activity in a cellular model of human insulin resistance
- (2018) Chong Feng et al. GYNECOLOGICAL ENDOCRINOLOGY
- Hesperidin inhibits insulin-induced phosphoinositide 3–kinase/Akt activation in human pre-B cell line NALM-6
- (2018) SayedHossein Davoodi et al. Journal of Cancer Research and Therapeutics
- X-linked inhibitor of apoptosis protein inhibitor Embelin induces apoptosis via PI3K/Akt pathway and inhibits invasion in osteosarcoma cells
- (2018) Tao Huang et al. Journal of Cancer Research and Therapeutics
- MicroRNA-150 enhances radiosensitivity by inhibiting the AKT pathway in NK/T cell lymphoma
- (2018) Shao Jie Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- NF-κB signaling and its relevance to the treatment of mantle cell lymphoma
- (2018) Swathi Balaji et al. Journal of Hematology & Oncology
- Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer
- (2018) Sen Xu et al. MOLECULAR CANCER THERAPEUTICS
- EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation
- (2018) Jong-Ho Lee et al. MOLECULAR CELL
- Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway
- (2018) Chendong Yang et al. OncoTargets and Therapy
- RACK1 induces chemotherapy resistance in esophageal carcinoma by upregulating the PI3K/AKT pathway and Bcl-2 expression
- (2018) Bowen Liu et al. OncoTargets and Therapy
- The roles of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated proteins (MRPs/ABCCs) in the excretion of cycloicaritin-3-O-glucoronide in UGT1A1-overexpressing HeLa cells
- (2018) Shishi Li et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Macrophages confer resistance to PI3K inhibitor GDC-0941 in breast cancer through the activation of NF-κB signaling
- (2018) Muhammad Waqas Usman et al. Cell Death & Disease
- Targeting the Multidrug Transporter Ptch1 Potentiates Chemotherapy Efficiency
- (2018) Anida Hasanovic et al. Cells
- Anti-tumor activity of Shikonin against afatinib resistant non-small cell lung cancer via negative regulation of PI3K/Akt signaling pathway
- (2018) Baiying Li et al. BIOSCIENCE REPORTS
- Down-regulation of ABCE1 inhibits temozolomide resistance in glioma through the PI3K/Akt/NF-κB signaling pathway
- (2018) Peng Zhang et al. BIOSCIENCE REPORTS
- Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities
- (2018) Sherri Z. Millis et al. CANCER
- Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next Generation Sequencing for Matching Patients to Targeted and Immune Therapies
- (2018) James J Harding et al. CLINICAL CANCER RESEARCH
- Therapeutic Suppression of mTOR (Mammalian Target of Rapamycin) Signaling Prevents and Reverses Salt-Induced Hypertension and Kidney Injury in Dahl Salt-Sensitive Rats
- (2018) Vikash Kumar et al. HYPERTENSION
- Ferulic acid reverses P-glycoprotein-mediated multidrug resistance via inhibition of PI3K/Akt/NF-κB signaling pathway
- (2018) Ganesan Muthusamy et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Targeting glycometabolic reprogramming to restore the sensitivity of leukemia drug-resistant K562/ADM cells to adriamycin
- (2018) Xueyan Zhang et al. LIFE SCIENCES
- Dynamic genome and transcriptional network-based biomarkers and drugs: precision in breast cancer therapy
- (2018) Ioannis D. Kyrochristos et al. MEDICINAL RESEARCH REVIEWS
- 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells
- (2018) Sara Ranjbar et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- NOR1 Suppresses Cancer Stem-Like Cells Properties of Tumor Cells via the Inhibition of the AKT-GSK-3β-Wnt/β-catenin-ALDH1A1 Signal Circuit
- (2017) Wei Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Oxymatrine induces nasopharyngeal cancer cell death through inhibition of PI3K/AKT and NF-κB pathways
- (2017) Zhili Ni et al. Molecular Medicine Reports
- Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway
- (2017) Xueyan Zhang et al. Molecular Medicine Reports
- Chemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneity
- (2017) Aman Sharma Nanomedicine
- 14,15-EET Suppresses Neuronal Apoptosis in Ischemia–Reperfusion Through the Mitochondrial Pathway
- (2017) Hui-Xia Geng et al. NEUROCHEMICAL RESEARCH
- Scutellaria barbata D. Don inhibits 5-fluorouracil resistance in colorectal cancer by regulating PI3K/AKT pathway
- (2017) Jiumao Lin et al. ONCOLOGY REPORTS
- Luteolin inhibits cell proliferation and induces cell apoptosis via down-regulation of mitochondrial membrane potential in esophageal carcinoma cells EC1 and KYSE450
- (2017) Ping Chen et al. Oncotarget
- Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles
- (2017) Vanessa Lopes-Rodrigues et al. Scientific Reports
- Chaetominine reduces MRP1-mediated drug resistance via inhibiting PI3K/Akt/Nrf2 signaling pathway in K562/Adr human leukemia cells
- (2016) Jingyun Yao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- La voie de signalisation PI3K-AKT-mTOR : description, développement thérapeutique, résistances, marqueurs prédictifs/pronostiques et applications thérapeutiques en cancérologie
- (2016) Thibault Brotelle et al. BULLETIN DU CANCER
- Amino Acids Rather than Glucose Account for the Majority of Cell Mass in Proliferating Mammalian Cells
- (2016) Aaron M. Hosios et al. DEVELOPMENTAL CELL
- Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP).
- (2016) Han C. Dan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Proton pump inhibitor pantoprazole inhibits the proliferation, self-renewal and chemoresistance of gastric cancer stem cells via the EMT/β-catenin pathways
- (2016) Shuitu Feng et al. ONCOLOGY REPORTS
- Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
- (2016) Paul F Mercer et al. THORAX
- Ursolic Acid Induces Apoptosis of Prostate Cancer Cells via the PI3K/Akt/mTOR Pathway
- (2015) Yan Meng et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- Immunohistochemical and molecular analysis of PI3K/AKT/mTOR pathway in esophageal carcinoma
- (2015) Konstantia E. Tasioudi et al. APMIS
- Metabolic Mechanisms of Drug Resistance in Leukemia
- (2015) Birgit Knoechel et al. Cell Metabolism
- Lessons from gain- and loss-of-function models of pro-survival Bcl2 family proteins: implications for targeted therapy
- (2015) Maja Sochalska et al. FEBS Journal
- The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer
- (2015) Seiji Mabuchi et al. GYNECOLOGIC ONCOLOGY
- Significance of NF-κB activation in immortalization of nasopharyngeal epithelial cells
- (2015) Dan Dan Zhu et al. INTERNATIONAL JOURNAL OF CANCER
- The PI3K/AKT/mTOR interactive pathway
- (2015) Tulin Ersahin et al. Molecular BioSystems
- HDAC inhibition prevents white matter injury by modulating microglia/macrophage polarization through the GSK3β/PTEN/Akt axis
- (2015) Guohua Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of PI3K inhibitor NVP-BKM120 on overcoming drug resistance and eliminating cancer stem cells in human breast cancer cells
- (2015) Y Hu et al. Cell Death & Disease
- PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex
- (2015) P. Liu et al. Cancer Discovery
- A Positive Feedback Loop between Akt and mTORC2 via SIN1 Phosphorylation
- (2015) Guang Yang et al. Cell Reports
- 3β-Acetyl tormentic acid reverts MRP1/ABCC1 mediated cancer resistance through modulation of intracellular levels of GSH and inhibition of GST activity
- (2014) Gleice da Graça Rocha et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Feroniellin A-induced autophagy causes apoptosis in multidrug-resistant human A549 lung cancer cells
- (2014) CHUTIMA KAEWPIBOON et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- 20(s)-ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K/Akt and XIAP pathways
- (2014) Jia-He Wang et al. TUMOR BIOLOGY
- Reduced methylation of PFKFB3 in cancer cells shunts glucose towards the pentose phosphate pathway
- (2014) Takehiro Yamamoto et al. Nature Communications
- Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention
- (2013) Xin Tong et al. Anti-Cancer Agents in Medicinal Chemistry
- Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists
- (2013) Kenneth K W To et al. BRITISH JOURNAL OF PHARMACOLOGY
- Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC
- (2013) Susan Heavey et al. CANCER TREATMENT REVIEWS
- The rheostat in the membrane: BCL-2 family proteins and apoptosis
- (2013) N Volkmann et al. CELL DEATH AND DIFFERENTIATION
- XIAP inhibits autophagy via XIAP-Mdm2-p53 signalling
- (2013) Xing Huang et al. EMBO JOURNAL
- Anti-tumor activity of the X-linked inhibitor of apoptosis (XIAP) inhibitor embelin in gastric cancer cells
- (2013) Da-Guang Wang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Activation of Akt pathway by transcription-independent mechanisms of retinoic acid promotes survival and invasion in lung cancer cells
- (2013) Alejandro García-Regalado et al. Molecular Cancer
- Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine
- (2013) XIA XIE et al. ONCOLOGY REPORTS
- Hydroxycamptothecin induces apoptosis and inhibits tumor growth in colon cancer by the downregulation of survivin and XIAP expression
- (2013) Bojian Fei et al. World Journal of Surgical Oncology
- Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria
- (2012) E A Roundhill et al. BRITISH JOURNAL OF CANCER
- Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy
- (2012) Bruno Fischer et al. LUNG CANCER
- Reactive oxygen species contribute to oridonin-induced apoptosis and autophagy in human cervical carcinoma HeLa cells
- (2011) Ya-hong Zhang et al. ACTA PHARMACOLOGICA SINICA
- Fas death receptor signalling: roles of Bid and XIAP
- (2011) T Kaufmann et al. CELL DEATH AND DIFFERENTIATION
- Proteasome inhibitors sensitize glioma cells and glioma stem cells to TRAIL-induced apoptosis by PKCε-dependent downregulation of AKT and XIAP expressions
- (2011) Sarit Kahana et al. CELLULAR SIGNALLING
- Hyaluronan Inhibits Akt, Leading to Nuclear Factor-κB Down-Regulation in Lipopolysaccharide-Stimulated U937 Macrophages
- (2011) Tadashi Yasuda JOURNAL OF PHARMACOLOGICAL SCIENCES
- Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas
- (2009) Hua-Yun Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin
- (2009) Q. Zhou et al. MOLECULAR CANCER THERAPEUTICS
- The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
- (2008) Ralph J. DeBerardinis et al. Cell Metabolism
- Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis
- (2008) R. Brooks Robey et al. SEMINARS IN CANCER BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started